SCHEMBL24322203

SCHEMBL24322203

CCN1CCN(C(C)C)CC(F)(F)C1

nearest known ligand 0.37

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16434741 0.82 KDM4E (0.31)
SCHEMBL22951152 0.78
SCHEMBL23381122 0.76 KDM4E (0.30)
SCHEMBL684100 0.75 DAO (0.38)
SCHEMBL6660826 0.75 DAO (0.38)
SCHEMBL17482104 0.75 DAO (0.38)
SCHEMBL13815296 0.75 TSHR (0.32) TSHR
SCHEMBL683603 0.75
Hydrochloric Acid SCHEMBL2773837 0.73
SCHEMBL11991386 0.72 MC4R (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022061273-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS PRELUDE THERAPEUTICS, INCORPORATED (US) 2022-03-24 WO disclosed